Track the ME Therapeutics Holdings Inc. share price and the full insider trade history of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. Market capitalisation: €26.4m. The latest transaction was reported on 16 July 2026 (53 - Grant of warrants). Among the most active insiders: Priatel, John. Every trade is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200 shares@ CA$1.99100.0% of flowCommon SharesTSXSEDI:4741838
Canonical exit: 27 Sept 2026 (T+90)
15 of 15 declarations
Acerca de ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc. es una empresa que cotiza en la Bolsa de Valores de Toronto, especializada en el desarrollo de terapias innovadoras. Se enfoca en mejorar los tratamientos médicos a través de enfoques basados en la biotecnología.